UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

FSU’s medical music therapy for vulnerable babies to expand

Critically ill babies fighting for their lives will now benefit from the services of Florida…

Miami-Dade Makers Lab is a Bustling Hub for Creativity and Innovation

Miami Dade College Makers Lab at Wolfson Campus is a haven for hands-on learning and…

USF: Can Computer Brain Games Prevent Dementia?

In order to combat Alzheimer’s deteriorating effects on the minds of millions, the University of…